Science Explorer Interactive view Map
Company · Boston · United States

Alexion Pharmaceuticals (United States)

In research, Alexion Pharmaceuticals (United States) stands highest in Medicine (#4,908 of 17,978 worldwide), Life Sciences (#4,368 of 14,347 worldwide) and Health Sciences (#6,624 of 20,462 worldwide), over all time.

alexion.comROR OpenAlex
World rank, 2022–2025
#12,600
of 28,054 · #9,625 all time
Rank in United States
#1,724
of 4,192
Research works
360
▲ 85% vs 2013–17
Citations
14k
39.9 per fractional work
Top-10% rate
18.6%
record average 16.5%
Open access
46%
world 28%

What is Alexion Pharmaceuticals (United States) known for in research?

The fields where it stands highest, over all time, ranked among every institution above the floor in each field.

FieldWorld rankWhere that sitsTop-10% rateWorks
MedicineField #4,908 of 17,978 24.4%184
Life SciencesDomain #4,368 of 14,347 25.5%128
Health SciencesDomain #6,624 of 20,462 23.7%193

Each strip is that field’s whole ranked pool, with the notch where Alexion Pharmaceuticals (United States) sits in it, in the colour of the band that rank falls in. The track under the rate is the rate itself: it carries no world mark, because the world rate differs by field (from about 6% to 21% in this record).

Field profile

Location quotient across every field it publishes in: outside the ring is more than an institution of this size would be expected to publish, inside it is less.

Agricultural and Biological Sciences: 0.20× its world share, 1 worksAgricultural and Bio…Biochemistry, Genetics and Molecular Biology: 2.91× its world share, 12 worksBiochemistry, Geneti…Immunology and Microbiology: 7.38× its world share, 6 worksImmunology and Micro…Neuroscience: 0.37× its world share, 0 worksNeurosciencePharmacology, Toxicology and Pharmaceutics: 2.06× its world share, 1 worksPharmacology, Toxico…Chemical Engineering: 0.61× its world share, 0 worksChemical EngineeringChemistry: 0.48× its world share, 1 worksChemistryComputer Science: 0.42× its world share, 3 worksComputer ScienceEnergy: 0.53× its world share, 0 worksEnergyEngineering: 0.15× its world share, 2 worksEngineeringEnvironmental Science: 0.28× its world share, 1 worksEnvironmental ScienceMaterials Science: 0.02× its world share, 0 worksMaterials ScienceMathematics: 0.44× its world share, 0 worksMathematicsPhysics and Astronomy: 0.19× its world share, 0 worksPhysics and AstronomyHealth Professions: 1.05× its world share, 2 worksHealth ProfessionsMedicine: 2.86× its world share, 43 worksMedicineNursing: 3.51× its world share, 1 worksNursingVeterinary: 2.81× its world share, 0 worksVeterinaryArts and Humanities: 0.06× its world share, 0 worksArts and HumanitiesBusiness, Management and Accounting: 0.07× its world share, 0 worksBusiness, Management…Decision Sciences: 0.06× its world share, 0 worksDecision SciencesEconomics, Econometrics and Finance: 1.25× its world share, 2 worksEconomics, Econometr…Psychology: 0.36× its world share, 1 worksPsychologySocial Sciences: 0.10× its world share, 1 worksSocial Sciences1×world share
more than its size predictsabout as predictedless

Rings at 0.5×, 1× and 2×. Widest outward: Immunology and Microbiology, 7.4×. Every wedge is a field page.

Who are the top researchers at Alexion Pharmaceuticals (United States)?

Ranked on the composite score, Louis A. Matis, Scott A. Rollins and Camille L. Bedrosian lead among researchers whose main affiliation is Alexion Pharmaceuticals (United States).

  1. 1 Louis A. Matis United States · #387,691 worldwide 108 citations · 18 works
  2. 2 Scott A. Rollins United States · #445,389 worldwide 83 citations · 18 works
  3. 3 Camille L. Bedrosian United States · #1,150,402 worldwide 26 citations · 18 works
All ranked researchers at Alexion Pharmaceuticals (United States)

Which keywords describe research at Alexion Pharmaceuticals (United States)?

By fractional works in 2022–2025, weighted toward what it does more of than the world: Prognosis, Autoantibodies, Immunotherapy, Treatment, Diagnosis, Innate Immunity, Genetics and Regulation.

▲ more of its work than of the world’s◆ about the world’s share▼ less than the world’s

Size is fractional works in 2022–2025 in the topics tagged with each word; colour is the word's share of this institution's work against its share of the world's. The 40 words are chosen for being large and distinctive. Each links to the topic it comes from most.

All 40 words, with their numbers
  1. Prognosis9▲ 35×5 topics
  2. Epidemiology7▲ 2.3×20 topics
  3. Treatment6▲ 6.1×14 topics
  4. Autoantibodies6▲ 30×8 topics
  5. Diagnosis5▲ 7.2×12 topics
  6. Immunotherapy5▲ 9.4×6 topics
  7. Innate Immunity5▲ 18×7 topics
  8. Genetics4▲ 8.2×6 topics
  9. Regulation4▲ 9.8×3 topics
  10. Neuromuscular Junction4▲ 126×2 topics
  11. Complement4▲ 299×1 topic
  12. Immune4▲ 299×1 topic
  13. Inflammatory Diseases4▲ 28×3 topics
  14. Oxidative Stress4▲ 3.1×16 topics
  15. Myasthenia Gravis4▲ 249×1 topic
  16. Thymic Tumors4▲ 249×1 topic
  17. Neurological Disorders3▲ 7.4×6 topics
  18. Genetic Mutations3▲ 9.1×9 topics
  19. Cardiac Amyloidosis3▲ 183×1 topic
  20. Cardiovascular Magnetic Resonance3▲ 72×2 topics
  21. Transthyretin3▲ 183×1 topic
  22. Anemia2▲ 30×3 topics
  23. Chronic Kidney Disease2▲ 12×6 topics
  24. Glomerular Diseases2▲ 88×1 topic
  25. Nephrotic Syndrome2▲ 88×1 topic
  26. Monoclonal Antibodies2▲ 30×3 topics
  27. Parathyroid Hormone2▲ 28×2 topics
  28. Glycosylation2▲ 22×3 topics
  29. Thrombosis2▲ 8.1×5 topics
  30. Cognitive Impairment2▲ 8.6×5 topics
  31. Diagnostic Criteria2▲ 9.8×6 topics
  32. Genetic Variants2▲ 13×4 topics
  33. Therapeutic Antibodies2▲ 31×2 topics
  34. FGF232▲ 60×1 topic
  35. Genetic Regulation2▲ 12×2 topics
  36. Pancreatic Cancer2▲ 19×2 topics
  37. phosphate2▲ 60×1 topic
  38. Alloimmunization2▲ 75×1 topic
  39. Cost-effectiveness Analysis2▲ 23×1 topic
  40. Health Utility Measures2▲ 23×1 topic

Which research topics does Alexion Pharmaceuticals (United States) publish most on?

By volume in 2022–2025: Complement system in diseases, Myasthenia Gravis and Thymoma, Amyloidosis: Diagnosis, Treatment, Outcomes and Renal Diseases and Glomerulopathies.

Complement system in diseases: 4 fractional worksMyasthenia Gravis and Thymoma: 4 fractional worksAmyloidosis: Diagnosis, Treatment, Outcomes: 3 fractional worksRenal Diseases and Glomerulopathies: 2 fractional worksParathyroid Disorders and Treatments: 2 fractional worksHealth Systems, Economic…2Health Systems, Economic Evaluations, Quality of Life: 2 fractional worksBlood groups and transfusion: 2 fractional worksCoagulation, Bradykinin, Polyphosphates, and Angioedema: 1 fractional worksMonoclonal and Polyclonal Antibodies Research: 1 fractional worksHemoglobinopathies and Related Disorders: 1 fractional works
ImmunologyNeurologyMolecular BiologyNephrology4 others

Area is fractional works; colour is the subfield each topic belongs to.

  1. 1 Complement system in diseases Immunology 4 works
  2. 2 Myasthenia Gravis and Thymoma Neurology 4 works
  3. 3 Amyloidosis: Diagnosis, Treatment, Outcomes Molecular Biology 3 works
  4. 4 Renal Diseases and Glomerulopathies Nephrology 2 works
  5. 5 Parathyroid Disorders and Treatments Nephrology 2 works
  6. 6 Health Systems, Economic Evaluations, Quality of Life Economics and Econometrics 2 works
  7. 7 Blood groups and transfusion Hematology 2 works
  8. 8 Coagulation, Bradykinin, Polyphosphates, and Angioedema Genetics 1 works
  9. 9 Monoclonal and Polyclonal Antibodies Research Radiology, Nuclear Medicine and Imaging 1 works
  10. 10 Hemoglobinopathies and Related Disorders Genetics 1 works

How open and international is its research?

Against the world’s own shares — the tick on each track. Both are shares of its output, so they sit on one scale and can be read against each other as well as against the world.

openly available46.5%not open53.5%

World: 28% of research is openly available.

with international co-authors42.1%domestic only57.9%

World: 19% is written across borders.

How has Alexion Pharmaceuticals (United States)'s research output changed?

Output in 2018–2022 was 85% higher than in 2013–2017.

1990200020102020
grewheldshrank

The same series as a ribbon — one cell per year, darker for more. The line above answers how much; this answers when.

Other research institutions in Boston

All research institutions in Boston

Research measures only: rankings here say nothing about teaching, admissions or student experience. Comparable institutions and collaboration partners are in the interactive view on the map.